Co-Diagnostics, Inc. Gains 106.26%
Wed, Feb 26, 2020 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) shot up at $8.9, a gain of 106.3%. On Tue 25 Feb 20, CODX:NASDAQ touched a New 2-Week High of $4.32. The stock got featured on our News Catalysts scanner on Tue 25 Feb 20 at 08:15 PM in the 'MISCELLANEOUS' category. From Tue 04 Feb 20, the stock recorded 50.00% Up Days and 60.00% Green Days
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Tonix Pharmaceuticals Holding Corp. (TNXP:NASDAQ), 122.55%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 106.26%
- Vir Biotechnology, Inc. (VIR:NASDAQ), 60.95%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 48.68%
- Vaxart, Inc. (VXRT:NASDAQ), 36.36%
- Tarena International, Inc. (TEDU:NASDAQ), 35.46%
- SELLAS Life Sciences Group, Inc. (SLS:NASDAQ), 27.54%
- Lianluo Smart Limited (LLIT:NASDAQ), 25.66%
- Remark Holdings, Inc. (MARK:NASDAQ), 24.14%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 23.9%